Suppr超能文献

FOXM1及其在胰腺癌发病机制中的致癌信号传导。

FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.

作者信息

Huang Chen, Du Jiawei, Xie Keping

机构信息

Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai, People's Republic of China; Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Department of Laboratory Medicine, Zhenjiang Second People's Hospital, Jiangsu University College of Medicine, Zhenjiang, People's Republic of China.

出版信息

Biochim Biophys Acta. 2014 Apr;1845(2):104-16. doi: 10.1016/j.bbcan.2014.01.002. Epub 2014 Jan 11.

Abstract

Pancreatic cancer is a devastating disease with an overall 5-year survival rate less than 5%. Multiple signaling pathways are implicated in the pathogenesis of pancreatic cancer, such as Wnt/β-catenin, Notch, Hedgehog, hypoxia-inducible factor, signal transducer and activator of transcription, specificity proteins/Krüppel-like factors, and Forkhead box (FOX). Recently, increasing evidence has demonstrated that the transcription factor FOXM1 plays important roles in the initiation, progression, and metastasis of a variety of human tumors, including pancreatic cancer. In this review, we focus on the current understanding of the molecular pathogenesis of pancreatic cancer with a special focus on the function and regulation of FOXM1 and rationale for FOXM1 as a novel molecular target for pancreatic cancer prevention and treatment.

摘要

胰腺癌是一种极具毁灭性的疾病,其总体5年生存率低于5%。多种信号通路与胰腺癌的发病机制有关,如Wnt/β-连环蛋白、Notch、Hedgehog、缺氧诱导因子、信号转导和转录激活因子、特异性蛋白/Krüppel样因子以及叉头框(FOX)。最近,越来越多的证据表明,转录因子FOXM1在包括胰腺癌在内的多种人类肿瘤的发生、发展和转移中发挥着重要作用。在本综述中,我们重点关注目前对胰腺癌分子发病机制的理解,特别关注FOXM1的功能和调控,以及FOXM1作为胰腺癌预防和治疗新分子靶点的理论依据。

相似文献

1
FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.
Biochim Biophys Acta. 2014 Apr;1845(2):104-16. doi: 10.1016/j.bbcan.2014.01.002. Epub 2014 Jan 11.
2
A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.
Cancer Res. 2012 Feb 1;72(3):655-65. doi: 10.1158/0008-5472.CAN-11-3102. Epub 2011 Dec 22.
3
FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
Clin Cancer Res. 2014 May 15;20(10):2595-606. doi: 10.1158/1078-0432.CCR-13-2407. Epub 2014 Mar 14.
4
Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Cancer Res. 2013 Jul 1;73(13):3987-96. doi: 10.1158/0008-5472.CAN-12-3859. Epub 2013 Apr 18.
7
Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.
Cancer Res. 2015 Nov 15;75(22):4778-4789. doi: 10.1158/0008-5472.CAN-14-1952. Epub 2015 Oct 19.
8
Targeting miRNAs for pancreatic cancer therapy.
Curr Pharm Des. 2014;20(33):5279-86. doi: 10.2174/1381612820666140128210443.
9
The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.
Clin Cancer Res. 2013 Jan 1;19(1):62-72. doi: 10.1158/1078-0432.CCR-12-1588. Epub 2012 Nov 7.
10
Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.
Curr Drug Targets. 2013 Sep;14(10):1192-202. doi: 10.2174/13894501113149990192.

引用本文的文献

1
FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance.
Int J Biol Sci. 2025 Jan 13;21(3):1047-1064. doi: 10.7150/ijbs.105289. eCollection 2025.
2
Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression.
Genes Dis. 2023 Dec 22;11(5):101203. doi: 10.1016/j.gendis.2023.101203. eCollection 2024 Sep.
3
Deciphering cellular plasticity in pancreatic cancer for effective treatments.
Cancer Metastasis Rev. 2024 Mar;43(1):393-408. doi: 10.1007/s10555-023-10164-5. Epub 2024 Jan 9.
4
Loss of GATA6-mediated up-regulation of UTX promotes pancreatic tumorigenesis and progression.
Genes Dis. 2023 Mar 31;11(2):921-934. doi: 10.1016/j.gendis.2023.01.019. eCollection 2024 Mar.
5
MicroRNAs as the Critical Regulators of Forkhead Box Protein Family in Pancreatic, Thyroid, and Liver Cancers.
Biochem Genet. 2023 Oct;61(5):1645-1674. doi: 10.1007/s10528-023-10346-4. Epub 2023 Feb 13.
7
Multi-stage analysis of expression patterns in colorectal cancer.
Gastroenterol Hepatol Bed Bench. 2022 Spring;15(2):120-130.
8
CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway.
Cell Death Discov. 2022 Jun 29;8(1):300. doi: 10.1038/s41420-022-01079-1.
10
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.
Cancers (Basel). 2021 Jun 19;13(12):3065. doi: 10.3390/cancers13123065.

本文引用的文献

2
Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Cancer Res. 2013 Jul 1;73(13):3987-96. doi: 10.1158/0008-5472.CAN-12-3859. Epub 2013 Apr 18.
3
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
Endocr Relat Cancer. 2012 Sep 21;19(5):695-710. doi: 10.1530/ERC-12-0031. Print 2012 Oct.
4
The oncogenic transcription factor FOXM1 and anticancer therapy.
Cell Cycle. 2012 Sep 15;11(18):3341-2. doi: 10.4161/cc.21841. Epub 2012 Aug 23.
5
The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.
Mol Cancer. 2012 Aug 17;11:56. doi: 10.1186/1476-4598-11-56.
7
FoxM1: a potential drug target for glioma.
Future Oncol. 2012 Mar;8(3):223-6. doi: 10.2217/fon.12.1.
8
Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.
PLoS One. 2012;7(2):e31761. doi: 10.1371/journal.pone.0031761. Epub 2012 Feb 29.
9
Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.
Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):25-35. doi: 10.1016/j.cytogfr.2012.01.003. Epub 2012 Feb 16.
10
FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Acta Histochem. 2012 Dec;114(8):755-62. doi: 10.1016/j.acthis.2012.01.002. Epub 2012 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验